We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Analytical Cannabis Logo
Home > Resources > Videos > Content Piece

Analytical Challenges in the European Cannabis Industry

Published: Feb 11, 2023   

Medical cannabis has shown efficacy through clinical trials and is being deployed legally in medical settings as a therapeutic for numerous conditions. However, there continues to be considerable variation in the regulatory approaches towards medical cannabis between European countries. Across Europe, various countries allow the use of cannabinoid containing medicinal products, and a growing number have established standalone medical cannabis programmes. The formal definition of ‘medical cannabis’ is often misinterpreted, and therefore its terminology has many grey areas. The European medical cannabis market lacks a common regulatory framework and there is a pressing need to develop clear policies and regulations across territories to foster harmonisation. The highly regulated nature of this sector demands rigorous quality control measures that require advanced analytical techniques to ensure product safety. The nature of the Cannabis plant and its status as an illegal and controlled narcotic in many countries, adds a level of complexity to the development of harmonised analytical protocols. This talk will highlight some of the analytical challenges facing this developing sector.

  More Information

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter